Skip to main content

TRUIST FINANCIAL CORP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 92230 CHARLOTTE, NC

Position in REGN

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$30,989,044
+$1,317,591 QoQ
Shares Held
40,108
+4.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 32.24045078288621.ToString("F0")% Shared 0.029919218111100033.ToString("F0")% None 67.7296299990027.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TRUIST FINANCIAL CORP holds $112,535,820 across 48 Biotechnology names. REGN ranks #2 (27.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
40,108 $30,989,044

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,989,044 40,108
2025-12-31 $29,671,453 38,441
2025-09-30 $21,617,031 38,446
2025-06-30 $20,448,225 38,949
2025-03-31 $28,053,894 44,233
2024-12-31 $42,243,305 59,303
2024-09-30 $39,012,566 37,111
2024-06-30 $42,273,476 40,221
2024-03-31 $40,281,167 41,851
2023-12-31 $38,979,386 44,381
2023-09-30 $43,158,490 52,443
2023-06-30 $58,171,559 80,958
2023-03-31 $77,900,065 94,807
2022-12-31 $80,039,213 110,936
2022-09-30 $80,683,898 117,125
2022-06-30 $74,296,173 125,685
2022-03-31 $94,932,039 135,924
2021-12-31 $90,013,069 142,534
2021-09-30 $86,371,893 142,721
2021-06-30 $83,668,173 149,798
2021-03-31 $61,855,956 130,735
2020-12-31 $35,925,989 74,364
2020-09-30 $37,283,025 66,603
2020-06-30 $45,160,365 72,413
2020-03-31 $32,096,275 65,732